The psychological impact of COVID-19 and restrictive measures in the world

Passavanti, Marco; Argentieri, Alessandro; Barbieri, Diego Maria; Lou, Baowen; Wijayaratna, Kasun; Mirhosseini, Ali Seyed Foroutan; Wang, Fusong; Naseri, Sahra; Qamhia, Issam I. A.; Tangerås, Marius; Pelliciari, Matteo; Ho, Chun Hsing

doi:10.1016/j.jad.2021.01.020

Cited by 145 publications

(168 citation statements)

References 88 publications

Supporting

Mentioning

145

Contrasting

Unclassified

Order By: Relevance

“…In addition, a recent study exploring the psychological impact of the pandemic and lockdown measures in subjects from seven different countries showed that a moderate use of the social networks (ie 1‐2 hours per day) was linked with less negative effects, as compared with excessive use or no use at all. Authors also underlined the role of social media as a protective factor 60 . Thus, in this context, results from the present study might have underestimated the effects possibly present in the general population and, in particular, in people who do not use social networks.…”

Section: Discussionmentioning

confidence: 55%

Multiplying effects of COVID‐19 lockdown on metabolic risk and fatty liver

Shanmugam

Ciaula

Palo

et al. 2021

Eur J Clin Investigation

View full text Add to dashboard Cite

Background Social containment measures imposed in Europe during the lockdown to face COVID‐19 pandemic can generate long‐term potential threats for metabolic health. Methods A cohort of 494 non‐COVID‐19 subjects living in 21 EU countries were interviewed by an anonymous questionnaire exploring anthropometric and lifestyle changes during 1‐month lockdown. A subgroup of 41 overweight/obese Italian subjects with previously diagnosed nonalcoholic fatty liver (NAFLD) joined the study following a 12‐month follow‐up period promoting weight loss by healthy lifestyle. Results During the lockdown, body weight increased in 55% of subjects (average 2.4 ± 0.9 kg). Weight change increased with age, but not baseline body mass index. Subjects living in Italy had greater weight gain than those living in other European Countries. Weight gain during the lockdown was highest in subjects reporting no physical activity, and low adherence to Mediterranean diet. In the NAFLD group, weight gain occurred in 70% of cases. Subjects reporting weight loss during lockdown had decreased fatty liver score at 3 months before the lockdown, as compared with 1 year before. Conclusions Strict measures of social containment—even short‐term—pave the way to the increased risk of metabolic abnormalities in the medium‐long term. In this context, adherence to Mediterranean diet and regular physical activity play a protective role both in terms of weight gain and fatty liver development/progression, with implication for primary and secondary prevention. When adopting measures imposing social containment, intensive educational campaigns must increase public awareness about beneficial effects of healthy lifestyles.

show abstract

Section: Discussionmentioning

confidence: 55%

Multiplying effects of COVID‐19 lockdown on metabolic risk and fatty liver

Shanmugam

Ciaula

Palo

et al. 2021

Eur J Clin Investigation

View full text Add to dashboard Cite

show abstract

“…This increase in anxiety, depression and fear reactions in patients with multiple sclerosis can be related to many factors. In the general population, physical distancing, economic tensions, labor difficulties, quarantines, are some of the causes related to worse mental health ( Passavanti et al, 2021 ). However, PwMS have additional concerns that are directly related to the characteristics of the disease ( Ahadi et al, 2020 ).…”

Section: Discussionmentioning

confidence: 99%

Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple Sclerosis

Broche-Pérez

Jiménez-Morales²,

Monasterio-Ramos³

et al. 2021

Multiple Sclerosis and Related Disorders

View full text Add to dashboard Cite

Background During the current COVID-19 pandemic there are studies that have suggested a negative impact of the pandemic on the mental health of patients with multiple sclerosis (PwMS). In this sense, several factors may be related to the increase in experiences of anxiety and depression in PwMS during the current pandemic. Objective In this study we first explored the reactions of anxiety, depression and fear to COVID-19 in a group of PwMS that belong to the Ibero-American region. Besides, we explored whether having been positive to COVID-19, fear of COVID-19, the obstacles to attend medical appointments during the outbreak and subjective experience of MS progression, could predict the anxiety and depression reactions in our PwMS sample. Materials and methods : An online cross-sectional survey was conducted on 202 MS patients from six countries (Argentina, Mexico, Spain, Dominican Republic, Venezuela and Cuba). For comparisons between variables an independent-samples t-test and one-way analysis of variance were used. Multiple linear regression was used to evaluate the effects of potential predictor variables over emotional reactions. Results Our results showed that PwMS who were positive for COVID-19 reported higher levels of fear of COVID-19 (p<.001) and also higher levels of anxiety (p<.001) compared to non-positive patients. Those patients who had difficulties attending their medical appointments during the outbreak showed higher levels of depression (p=.03) and anxiety (p=.019). Levels of anxiety (p<.001) and depression (p=.006) were also higher among patients with the subjective experience of MS disease progression. The reactions of fear of COVID-19, having been positive to COVID-19, problems attending medical appointments, and subjective experience of MS disease progression showed a high association with the negative impact of the pandemic on mental health of PwMS. Conclusions Our results show that the situation generated by the COVID-19 pandemic has had a negative impact on the mental health of PwMS in our sample. Our results also alert to the importance of offering psychological care to patients with multiple sclerosis during the current outbreak, regardless of whether they have been positive for COVID-19.

show abstract

“…The severity of insomnia was related to symptoms of depression and anxiety [ 99 ]. Research conducted during the initial stage of COVID-19 had highlighted its impact on mental health, with many people showing anxiety and depression [ 100 , 101 ], facing the risk of post-traumatic stress disorder [ 102 ].…”

Section: The ‘Three Syndromes and Six Chinese Patent Medicines’ Projectmentioning

confidence: 99%

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

Duan

Zhang

et al. 2021

Chin Med

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), first broke out in Wuhan, China, in 2019. SARS-CoV-2 develops many types of mutations (such as B.1.1.7), making diagnosis and treatment challenging. Although we now have a preliminary understanding of COVID-19, including pathological changes, clinical manifestations, and treatment measures, we also face new difficulties. The biggest problem is that most COVID-19 patients might face sequelae (e.g., fatigue, sleep disturbance, pulmonary fibrosis) during the recovery phase. We aimed to test six Chinese patent medicines to treat three major abnormal symptoms in COVID-19 patients during the recovery phase, including cardiopulmonary function, sleep disturbance, and digestive function. We launched the “three syndromes and six Chinese patent medicines” randomized, double-blind, placebo-controlled, multicenter clinical trial on April 10, 2020. The results showed that Jinshuibao tablets and Shengmaiyin oral liquid significantly improved the cardiopulmonary function of recovering COVID-19 patients. Shumian capsules, but not Xiaoyao capsules, significantly improved patients’ sleep disorders. This might be because the indication of Xiaoyao capsules is liver qi stagnation rather than psychological or emotional problems. Xiangsha Liujun pills and Ludangshen oral liquid significantly improved digestive function. Our research provides a guideline for treating COVID-19 sequelae in patients during the recovery period based on high-quality evidence.

show abstract

The psychological impact of COVID-19 and restrictive measures in the world

Cited by 145 publications

References 88 publications

Multiplying effects of COVID‐19 lockdown on metabolic risk and fatty liver

Multiplying effects of COVID‐19 lockdown on metabolic risk and fatty liver

Fear of COVID-19, problems accessing medical appointments, and subjective experience of disease progression, predict anxiety and depression reactions in patients with Multiple Sclerosis

The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19

Contact Info

Product

Resources

About